According to Edwards Lifesciences's latest financial reports the company's total liabilities are S$3.60 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | S$4.06 B | 16.49% |
2023-12-31 | S$3.49 B | 4.78% |
2022-12-31 | S$3.33 B | -7.56% |
2021-12-31 | S$3.60 B | 2.34% |
2020-12-31 | S$3.52 B | 11.67% |
2019-12-31 | S$3.15 B | 5.76% |
2018-12-31 | S$2.98 B | -17.72% |
2017-12-31 | S$3.62 B | 32.45% |
2016-12-31 | S$2.73 B | 24.57% |
2015-12-31 | S$2.19 B | 24.87% |
2014-12-31 | S$1.75 B | 19.15% |
2013-12-31 | S$1.47 B | 62.69% |
2012-12-31 | S$0.90 B | 9.06% |
2011-12-31 | S$0.83 B | 40.75% |
2010-12-31 | S$0.59 B | -7.97% |
2009-12-31 | S$0.64 B | -13.84% |
2008-12-31 | S$0.74 B | 1.58% |
2007-12-31 | S$0.73 B | -3.76% |
2006-12-31 | S$0.76 B | -15.03% |
2005-12-31 | S$0.89 B | 13.54% |
2004-12-31 | S$0.79 B | -0.21% |
2003-12-31 | S$0.79 B | -1.81% |
2002-12-31 | S$0.80 B | -16.85% |
2001-12-31 | S$0.97 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Boston Scientific BSX | S$22.54 B | 525.08% | ๐บ๐ธ USA |
![]() Merit Medical MMSI | S$1.32 B | -63.28% | ๐บ๐ธ USA |
![]() LeMaitre Vascular LMAT | S$0.26 B | -92.64% | ๐บ๐ธ USA |
![]() Medtronic MDT | S$51.41 B | 1,325.73% | ๐ฎ๐ช Ireland |
![]() ICU Medical
ICUI | S$2.79 B | -22.39% | ๐บ๐ธ USA |